Condition: Amyotrophic Lateral Sclerosis (ALS) · Sponsor: Universidade Federal do Rio Grande do Norte
Amyotrophic Lateral Sclerosis (ALS) is a nervous system disease that causes muscle weakness and rapidly progresses to the loss of mobility and functionality. Studies suggest that High-Definition Transcranial Direct Current Stimulation (HD-tDCS) is a technique for modulating motor cortical hyperexcitability. However, evidence on the use of HD-tDCS as a neuromodulator of the diaphragmatic motor cortex in people with ALS is inconclusive.
This description comes directly from the study's public registry record.
Guilherme A. F Fregonezi, PhD · +55(84)99426-7896 · guilherme.fregonezi@ufrn.br
Edna K. F Laurentino, MSc · +55(84)99471-5172 · ednakarlaferreira@gmail.com
Always discuss trial participation with your own doctor first.
| Universidade de Brasília - Campus Ceilândia | Brasília, Federal District, Brazil | Recruiting |
| PneumoCardioVascular Lab - HUOL/UFRN | Natal, Rio Grande do Norte, Brazil | Recruiting |
| Universidad Autónoma de Chile | Santiago, Santiago Metropolitan, Chile | Not Yet Recruiting |
| Universidad do Chile | Santiago, Santiago Metropolitan, Chile | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06719947